How has been the historical performance of Maitreya Medica.?
Maitreya Medica's historical performance has shown fluctuations, with net sales decreasing from INR 47.80 crore in March 2024 to INR 46.66 crore in March 2025, and declines in profitability metrics, while cash flow from operating activities improved to INR 5.00 crore. Overall, the company experienced variability in financial performance over the past four years.
Answer:The historical performance of Maitreya Medica shows fluctuations in key financial metrics over the past four years.Breakdown:
Maitreya Medica's net sales decreased slightly from INR 47.80 crore in March 2024 to INR 46.66 crore in March 2025, following a peak of INR 49.41 crore in March 2022 and a lower figure of INR 39.38 crore in March 2023. The total operating income mirrored this trend, remaining at INR 46.66 crore in March 2025. The total expenditure, excluding depreciation, decreased to INR 41.80 crore in March 2025 from INR 42.09 crore in March 2024. Operating profit (PBDIT) fell to INR 5.45 crore in March 2025 from INR 5.98 crore in the previous year, with a notable decline from INR 7.82 crore in March 2023. Profit before tax also decreased to INR 3.21 crore in March 2025, down from INR 3.90 crore in March 2024 and INR 5.93 crore in March 2023. Consequently, profit after tax dropped to INR 1.87 crore in March 2025 from INR 2.69 crore in March 2024 and INR 4.25 crore in March 2023. The earnings per share (EPS) reflected this decline, falling to INR 2.76 in March 2025 from INR 3.97 in March 2024 and INR 8.57 in March 2023. On the balance sheet, total assets increased to INR 47.99 crore in March 2025 from INR 43.86 crore in March 2024, while total liabilities also rose to INR 47.99 crore from INR 43.86 crore in the same period. Cash flow from operating activities improved to INR 5.00 crore in March 2025, recovering from a negative cash flow of INR -2.00 crore in March 2024. Overall, Maitreya Medica's financial performance has shown variability, with some recovery in cash flow but declines in profitability and sales in the most recent year.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
